Diagnostic technologies for neuroblastoma

作者：Leena Khelifa, Yubing Hu, Jennifer Tall, Rasha Khelifa, Amina Ali, Evon Poon, Mohamed Zaki Khelifa, Guowei Yang, Catarina Jones, Rosalia Moreddu, Nan Jiang, Savaş Taşoğlu, Louis Chesler, Ali K. Yetisen · 发表于：Lab on a Chip · 年份：2025 · DOI：10.1039/d4lc00005f · 被引用次数：14 · 研究领域：Neuroblastoma Research and Treatments、Ion channel regulation and function、Cancer, Hypoxia, and Metabolism

amplification and microRNAs (miRNAs). Using POC devices to detect high-risk biomarkers in biofluids such as blood and urine, offers a non-invasive approach to diagnosis of neuroblastoma, enabling early screening at a population level as well as real-time health monitoring at home. This is critical to mitigating long-term morbidity associated with late diagnosis and unnecessary treatment, in turn improving outcomes for neuroblastoma patients.